DrugDashboards

Sodium Sulfacetamide

Sodium Sulfacetamide · SULFACETAMIDE SODIUM 100 mg/mL · Liquid · Topical · Acella Pharmaceuticals, LLC

NDC 42192-0129-16 · 480 mL in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 11% over the past year, to $0.2399 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2$0.3Apr 2024Sep 2026$0.2399
25 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$168.49
Reported to Texas DSHS · 2026 annual filing · Acella Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$91,619
703 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for sulfacetamide sodium (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Sulfacetamide (Liquid)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackSULFACETAMIDE SODIUM 100 mg/gJul 15, 2026Sep 3, 2026
Acella Pharmaceuticals, LLCSULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Akron Pharma IncSULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Laser Pharmaceuticals, LLCSULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Method Pharmaceuticals, LLCSULFACETAMIDE SODIUM 100 mg/gJul 15, 2026Sep 2, 2026
Mission Pharmacal CompanySULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Oncor PharmaceuticalsSULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
BioComp Pharma, Inc.SULFACETAMIDE SODIUM 100 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Sulfacetamide — NDC 42192-0129-16," retrieved September 3, 2026, https://drugdashboards.com/drug/42192012916.

Free to cite with attribution — see how the data is put together.